<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0909211031
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2021
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Zencin
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        AZITHROMYCIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        250
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        6
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        29.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="(Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 437]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Middle East Pharmaceutical Industries Co Ltd Avalon Pharma
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01FA10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="direction:rtl">Zencin contains azithromycin which is one of a group of antibiotics known as macrolides.<br />It is used to treat bacterial infections caused by micro organisms such as bacteria. These<br />infections include:<br />&bull; Chest infections such as bronchitis and pneumonia.<br />&bull; Infections in your sinuses, throat, tonsils or ears.<br />&bull; Mild to moderate skin and soft tissue infections, e.g. infection of the hair follicles (folliculitis),<br />bacterial infection of the skin and its deeper layers (cellulitis), skin infection with shiny red<br />swelling (erysipelas).<br />&bull; Sexually transmitted disease caused by organisms called Chlamydia trachomatis and<br />Neisseria gonorrhoea.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Zencin<br />&bull; if you are allergic to azithromycin, any other macrolide (such as erythromycin or clarithromycin)<br />or ketolide antibiotic or any of the ingredients of this medicine (listed in section 6). An<br />allergic reaction may cause skin rash or wheezing.<br />Warnings and precautions<br />Talk to your doctor or pharmacist before taking Zencin if you:<br />&bull; have ever had a serious allergic reaction causing swelling of the face and throat, possibly<br />with breathing problems, rash, fever, swollen glands or increase in eosinophils (certain type<br />of white blood cells).<br />&bull; have severe kidney problems: your doctor may alter the dose.<br />&bull; have liver problems: your doctor may need to monitor your liver function or stop the treatment.<br />&bull; have myasthenia gravis (localised muscle weakness).<br />&bull; have been diagnosed with a neurological disease, which is a disease of the brain or<br />nervous system.<br />&bull; have mental, emotional or behavioural problems.<br />&bull; are taking medicines known as ergot alkaloids (such as ergotamine), which are used to treat<br />migraine: azithromycin is not recommended (see &lsquo;Other medicines and Zencin below).<br />Since azithromycin may increase the risk of abnormal heart rhythm please tell your<br />doctor if you have any of the following problems before taking this medicine (especially<br />you are female or elderly):<br />&bull; you are aware of ever being diagnosed to have prolonged QT interval (a heart condition,<br />shown on an electro-cardiogram or ECG machine): azithromycin is not recommended.<br />&bull; are aware that you have a slow or irregular heart beat, or reduced heart function (heart<br />failure): azithromycin is not recommended.<br />&bull; know that you have low levels of potassium or magnesium in your blood: azithromycin is<br />not recommended.<br />&bull; are taking medicines known as antiarrhythmics (e.g. quinidine, procainamide, dofetilide,<br />amiodarone, sotalol: used to treat abnormal heart rhythms), cisapride (used to treat stomach<br />problems) or terfenadine (an antihistamine that is used to treat allergies), or antipsychotic<br />agents (e.g. pimozide), antidepressants (e.g. citalopram), some antibiotics (e.g. moxifloxacin,<br />levofloxacin) that can affect the heart rhythm: Zencin is not recommended (see &lsquo;Other<br />medicines and Zencin below)<br />If you develop severe and persistent diarrhoea during or after treatment, especially if<br />you notice blood or mucus, tell your doctor immediately.<br />If your symptoms persist after the end of your treatment with Zencin, or if you notice<br />any new and persistent symptoms, contact your doctor.<br />Other medicines and Zencin<br />Tell your doctor before taking Zencin, if you are taking any of the medicines listed<br />below:<br />&bull; Warfarin or any similar medicine to prevent blood clots: concomitant use can increase the<br />risk of bleeding.<br />&bull; Ergotamine, dihydroergotamine (used to treat migraine): ergotism (ie. itching in the limbs,<br />muscle cramps and gangrene of hands and feet due to poor blood circulation) may occur.<br />Concomitant use is therefore not recommended.<br />&bull; Ciclosporin (used to suppress the immune system to prevent and treat rejection of an organ<br />or bone marrow transplant): if concomitant use is required, your doctor will check your blood<br />levels regularly and may adapt the dose.<br />&bull; Digoxin (for heart failure): digoxin levels may increase. Your doctor will check your blood levels.<br />&bull; Colchicine (used for gout and familial Mediterranean fever).<br />&bull; Antacids (for indigestion): Zencin should be taken at least 1 hour before or 2 hours after<br />the antacid.<br />&bull; Cisapride (for stomach problems), terfenadine (used to treat hay fever): concomitant use<br />with azithromycin may cause heart disorders.<br />&bull; Medicines for irregular heart beat (called anti-arrythmics), or to lower cholesterol (called<br />statins) such as atorvastatin.<br />&bull; Alfentanil (used for narcosis) or astemizole (used to treat hay fever): concomitant use with<br />azithromycin may increase the effect of these medicinal products.<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other<br />medicines.<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a<br />baby, ask your doctor or pharmacist for advice before taking this medicine.<br />Pregnancy<br />There is insufficient information regarding the safety of azithromycin during pregnancy.<br />Consequently, Azithromycin is not recommended if you are pregnant or planning to become<br />pregnant. However,your doctor may prescribe it under serious circumstances.<br />Breast-feeding<br />Azithromycin is excreted in human milk, therefore you should not breast-feed whilst you are taking Azithromycin, because it may cause side effects including diarrhoea and infection in your baby. It is recommended to discard the milk during treatment and up until 2 days after discontinuation of treatment. You may resume nursing two days after stopping your treatment with Azithromycin.</p><p>Driving and using machines<br />Azithromycin may cause dizziness and fits. If affected, do not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your<br />doctor or pharmacist if you are not sure.<br />Azithromycin tablets should be given as a single daily dose. The tablets should be swallowed<br />preferably with a drink of water, and can be taken with or without food.<br />Zencin 500mg: The tablet can&rsquo;t be divided into equal doses.<br />The recommended dose is:<br />Adults (including older patients), children and adolescents with a body weight of over 45 kg:<br />The recommended dose is 1500 mg divided over either 3 or 5 days as follows:<br />&bull; When taken over 3 days, 500 mg once daily.<br />&bull; When taken over 5 days, 500 mg as a single dose on the first day and then 250 mg once<br />daily on days 2 through to 5.<br />Inflammation of the urethra or cervix caused by Chlamydia: 1000 mg taken as a single dose,<br />for one day only.<br />For infections in your sinuses, treatment is indicated for adults and adolescents 16 years of<br />age and over.<br />Children and adolescents with a body weight of 45 kg and under:<br />Tablets are not indicated for these patients. Other pharmaceutical forms of azithromycin-containing<br />products (e.g. suspensions) may be used.<br />Patients with kidney or liver problems:<br />You should tell your doctor if you have kidney or liver problems as your doctor may need to<br />alter the normal dose.<br />Always continue with the course even if you feel better. If your infection gets worse or you do not<br />start to feel better within a few days or a new infection develops, go back and see your doctor.<br />If you take more Zencin than you should<br />If you (or someone else) swallow a lot of the tablets altogether, or if you think a child has swallowed<br />any of the tablets, contact your doctor or pharmacist immediately. An overdose is likely<br />to cause reversible hearing loss, severe nausea (feeling sick), vomiting and diarrhoea.<br />Please take this leaflet, any remaining tablets and the container with you to the hospital or<br />doctor so that they know which tablets were consumed.<br />If you forget to take Zencin<br />If you forget to take a tablet, take one as soon as you remember, unless it is nearly time to<br />take the next one. Do not take a double dose to make up for a forgotten dose.<br />If you stop taking Zencin<br />Do not stop taking your medicine without talking to your doctor first even if you feel better.<br />It is very important that you keep taking Zencin for as long as your doctor has told you to;<br />otherwise the infection may come back.<br />If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p dir="RTL">&nbsp;</p><div style="direction:ltr"><span style="text-align:unset">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></div><div style="direction:ltr"><span style="text-align:unset">If the following happens, stop taking the tablets and tell your doctor immediately or go</span></div><div style="direction:ltr"><span style="text-align:unset">to the Emergency department at your nearest hospital:</span></div><div style="direction:ltr"><span style="text-align:unset">Uncommon (may affect up to 1 in 100 people):</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; A severe skin reaction causing blisters/bleeding of the lips, eyes, nose, mouth and genitals</span></div><div style="direction:ltr"><span style="text-align:unset">(Stevens-Johnson syndrome).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; yellowing of the skin and whites of the eyes, tiredness and loss of appetite which may be</span></div><div style="direction:ltr"><span style="text-align:unset">caused by inflammation of the liver (hepatitis).</span></div><div style="direction:ltr"><span style="text-align:unset">Rare (may affect up to 1 in 1,000 people):</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; yellowing of the skin or eyes (jaundice).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; skin eruption that is characterised by the rapid appearance of areas of red skin studded with</span></div><div style="direction:ltr"><span style="text-align:unset">small pustules (small blisters filled with white/yellow fluid).</span></div><div style="direction:ltr"><span style="text-align:unset">Very rare (may affect up to 1 in 10,000 people):</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; skin rash accompanied by other symptoms such as fever, swollen glands and an increase of</span></div><div style="direction:ltr"><span style="text-align:unset">eosinophils (a type of white blood cell).</span></div><div style="direction:ltr"><span style="text-align:unset">Not known (frequency cannot be estimated from the available data):</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; an allergic reaction (swelling of the lips, face or neck leading to severe difficulty in breathing;</span></div><div style="direction:ltr"><span style="text-align:unset">skin rash or hives).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; severe peeling of the skin or an itchy rash with pink-red rings around a pale centre (toxic</span></div><div style="direction:ltr"><span style="text-align:unset">epidermal necrolysis, erythema multiforme).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; disturbances in heart rhythm called QT prolongation (delayed conduction of electrical signals</span></div><p dir="RTL">&nbsp;</p><div style="direction:ltr"><span style="text-align:unset">which can be seen on an ECG, an electrical recording of the heart). In some people this can</span></div><div style="direction:ltr"><span style="text-align:unset">develop into a potentially serious heart condition known as Torsades de pointes. This can</span></div><div style="direction:ltr"><span style="text-align:unset">result in a very fast heartbeat causing a sudden loss of consciousness.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; an irregular heart beat.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; feeling weak and breathless with yellowing of the skin which may be due to a reduced</span></div><div style="direction:ltr"><span style="text-align:unset">number of red blood cells due to destruction (haemolytic anaemia).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; prolonged diarrhoea with blood and mucus.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; stomach pain that moves to the back with feeling and being sick which may be caused by</span></div><div style="direction:ltr"><span style="text-align:unset">inflammation of the pancreas (pancreatitis).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; pain in the middle of the back and problems passing water, inflammation of the kidney or</span></div><div style="direction:ltr"><span style="text-align:unset">kidney failure.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; pain in the upper right of the stomach with feeling and being sick, swelling of the stomach,</span></div><div style="direction:ltr"><span style="text-align:unset">yellowing of the skin and eyes which may be due to liver failure (rarely life-threatening).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; fits.</span></div><div style="direction:ltr"><span style="text-align:unset">These are very serious side effects. You may need urgent medical attention or hospitalisation.</span></div><div style="direction:ltr"><span style="text-align:unset">The following side effects have been reported:</span></div><div style="direction:ltr"><span style="text-align:unset">Very common (may affect more than 1 in 10 people):</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; diarrhoea.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; feeling sick.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; abdominal pain.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; flatulence (wind).</span></div><div style="direction:ltr"><span style="text-align:unset">Common (may affect up to 1 in 10 people):</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; headache</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; dizziness, feeling drowsy (somnolence), taste disturbance, numbness or pins and needles</span></div><div style="direction:ltr"><span style="text-align:unset">(paraesthesia).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; visual disturbances.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; deafness.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; being sick.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; indigestion.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; skin rash.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; itching.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; joint pain (arthralgia).</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; tiredness.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; changes in white blood cell count in blood tests.</span></div><div style="direction:ltr"><span style="text-align:unset">&bull; low blood bicarbonate.</span></div><p dir="RTL" style="direction:ltr">Uncommon (may affect up to 1 in 100 people):<br />&bull; reduced sense of touch or sensation (hypoaesthesia).<br />&bull; changes in liver function.<br />&bull; skin more sensitive to light than normal.<br />&bull; yeast infections of the mouth and vagina (thrush), vaginal infections, fungal infections, bacterial<br />infections, inflammation of the throat, inflammation of the stomach and intestine, breathing<br />difficulties, runny or blocked nose.<br />&bull; allergic reactions of various severity.<br />&bull; loss of appetite.<br />&bull; feeling nervous.<br />&bull; sleeplessness (insomnia).<br />&bull; ear disorder, vertigo.<br />&bull; hearing impairment including hearing loss.<br />&bull; tinnitus (ringing in your ears).<br />&bull; heart palpitations.<br />&bull; hot flushes.<br />&bull; recurring frequent infections with fever, chills, sore throat, mouth ulcers, which may be<br />caused by a decrease in the number of white cells in the blood.<br />&bull; serious lung infection with symptoms such as fever, chills, shortness of breath, cough and<br />phlegm (pneumonia).<br />&bull; general swelling.<br />&bull; nose bleeds.<br />&bull; constipation, inflammation of the lining of the stomach (gastritis), difficulty swallowing,<br />feeling bloated, dry mouth, belching, mouth ulceration, saliva increased.<br />&bull; hives, inflammation of the skin (dermatitis), dry skin, increased sweating.<br />&bull; bone and joint pain, muscle pain, back pain, neck pain.<br />&bull; pain when passing urine, kidney pain.<br />&bull; abnormal or unexpected bleeding from the vagina.<br />&bull; problems with your testicles.<br />&bull; general loss of strength, generally feeling unwell, swelling of the face, chest pain, fever,<br />pain, swelling of the lower limbs.<br />&bull; abnormal laboratory test values (e.g. blood or liver tests).<br />&bull; post procedural complication.<br />&bull; shortness of breath.<br />Rare (may affect up to 1 in 1,000 people):<br />&bull; agitation<br />&bull; irritability.</p><p dir="RTL" style="direction:ltr">Not known (frequency cannot be estimated from the available data):<br />&bull; blood taking longer to clot and bruising more easily which may be due to a reduction in<br />number of platelets (thrombocytopenia),<br />&bull; aggression, anxiety, severe confusion (delirium), seeing, feeling or hearing things that are<br />not there (hallucination)<br />&bull; fainting, feeling hyperactive, loss of smell or altered sense of smell, loss of taste.<br />&bull; muscle weakness or worsening of muscle weakness (myasthenia gravis).<br />&bull; low blood pressure.<br />&bull; tongue discolouration.<br />&bull; tooth discolouration.<br />The following side effects have been reported in prophylactic treatment against Mycobacterium<br />Avium complex (MAC):<br />Very common (may affect more than 1 in 10 people):<br />&bull; diarrhoea.<br />&bull; abdominal pain.<br />&bull; feeling sick.<br />&bull; wind.<br />&bull; abdominal discomfort.<br />&bull; loose stools.<br />Common (may affect up to 1 in 10 people):<br />&bull; loss of appetite.<br />&bull; dizziness.<br />&bull; headache.<br />&bull; numbness or pins and needles (paraesthesia).<br />&bull; taste disturbance.<br />&bull; visual disturbances.<br />&bull; deafness.<br />&bull; skin rash and/or itching.<br />&bull; joint pain.<br />&bull; tiredness.<br />Uncommon (may affect up to 1 in 100 people):<br />&bull; reduced sense of touch or sensation (hypoaesthesia).<br />&bull; poor hearing or ringing in the ears.<br />&bull; heart palpitations.<br />&bull; skin more sensitive to sunlight than normal.<br />&bull; general loss of strength.<br />&bull; generally feeling unwell.</p><p dir="RTL" style="direction:ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; Keep this medicine out of the sight and reach of children.<br />&bull; Store below 30&deg;C.<br />&bull; Do not use this medicine after the expiry date which is stated on the label and carton. The<br />expiry date refers to the last day of that month.<br />&bull; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist<br />how to throw away medicines if you no longer use. These measures will help to protect the<br />environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Zencin film-coated tablet contains<br />&bull; The active substance is azithromycin.<br />Each tablet contains either 250 mg or 500 mg of the active ingredient azithromycin (as<br />Azithromycin Dihydrate).<br />&bull; The other ingredients are: Microcrystalline Cellulose, Pregelatinised Maize Starch, Sodium<br />Lauryl Sulphate, Dibasic Calcium Phosphate Anhydrous, Croscarmellose Sodium, Povidone<br />K30, Magnesium Stearate and Opadry White.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Zencin 250 mg tablets are white capsule shaped, biconvex, film coated tablet debossed with
‘C|25’ on one side and plain on the other side.
Zencin 500 mg tablets are white capsule shaped, biconvex, film coated tablet debossed with
‘C64’ on one side and ‘/’ on the other side.
The 250 mg tablets are available in pack size of 6 tablets in two blister strips.
The 500 mg tablets are available in pack size of 3 tablets in one blister strip.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Middle East Pharmaceutical Industries Co Ltd (Avalon Pharma)<br />P.O.Box 4180 Riyadh 11491, Kingdom of Saudi Arabia<br />2nd Industrial City, Riyadh, Kingdom of Saudi Arabia<br />Tel: +966 (11) 2653948 -2653427<br />Fax: +966 (11) 2654723</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>زينسين يحتوي على أزيثرومايسين وهو أحد مجموعات المضادات الحيوية التي يطلق عليها اسم الماكروليدات. وهو يستخدم لعلاج<br />حالات العدوى البكتيرية التي تسببها كائنات حية دقيقة مثل البكتريا. وتتضمن حالات العدوى تلك ما يلي:<br />&bull; عدوى الصدر مثل التهاب الشعب الهوائية والالتهاب الرئوي.<br />&bull; عدوى الجيوب الأنفية أو البلعوم )الحلق( أو اللوزتين أو الأذنين.<br />&bull; عدوى الجلد والأنسجة الرخوة من خفيفة إلى المتوسطة، مثل: عدوى بصيلات الشعر )التهاب الجريبات(، والعدوى البكتيرية في<br />الجلد وطبقاته العميقة )التهاب النسيج الخلوي(، والتهابات الجلد المصحوبة بتورم أحمر ولامع )الحمرة(.<br />&bull; الأمراض المنقولة جنسياً التي تسببها كائنات حية تدعى المتدثرة الحثرية )كلاميديا تراكوماتيس( والنيسرية البنية )نيسريا جونوريا(.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تتناول زينسين<br />&bull; إذا كنت تعاني من حساسية تجاه أزيثرومايسين أو غيره من المضادات الحيوية الماكروليدية )مثل إريثرومايسين أو كلاريثرومايسين(<br />أو كيتوليدي أو أي من مكونات هذا الدواء )المدرجة في القسم 6(. قد يسبب رد الفعل التحسسي بالإصابة بطفح جلدي أو أزيز.<br />التحذيرات والاحتياطات<br />تحدث مع طبيبك أو الصيدلي قبل تناول زينسين إذا كنت:<br />&bull; تعرضت من قبل لرد فعل تحسسي حاد يسبب تورمًا في الوجه والحلق، وقد يكون قد سبب صعوبة في التنفس، طفحًا جلديًا، حمى،<br />تورم الغدد أو زيادة في عدد اليوزينيات )نوع محدد في خلايا الدم البيضاء(.<br />&bull; مصابًا بإضطرابات خطيرة في الكلى: قد يغير الطبيب الجرعة.<br />&bull; مصابًا بإضطرابات في الكبد: قد يحتاج الطبيب إلى مراقبة وظائف الكبد أو وقف العلاج.<br />&bull; مصابًا بالوهن العضلي الوبيل )ضعف العضلات الموضعية(.<br />&bull; تم تشخيص إصابتك بمرض عصبي وهو مرض يصيب الدماغ أو الجهاز العصبي.<br />&bull; مصابًا بمشكلات عقلية أو انفعالية/عصبية أو سلوكية.<br />&bull; تتناول أدوية تُعرف باسم قلويدات الإرجوت )مثل أرجوتامين( التي تُستخدم لعلاج الصداع النصفي: لا يوصى بأزيثرومايسين<br />)انظر قسم &quot;الأدوية الأخرى وزينسين&quot; أدناه(.<br />نظرًا لأن أزيثرومايسين قد يزيد خطر الإصابة باضطراب نظم القلب، يرجى إخبار طبيبك قبل تناول هذا الدواء إذا كنت تعاني من<br />أي من المشكلات التالية )خاصة إذا كنتِ أنثى أو شخصًا كبير السن(:<br />الطويلة )حالة مرضية في القلب تظهر من خلال مخطط كهربائية القلب أو QT &bull; أنت على دراية بتشخيص إصابتك بفترة كيو تي<br />جهاز تخطيط القلب الكهربائي(: لا يوصى بالأزيثرومايسين.<br />&bull; أنت على دراية بتشخيص إصابتك بنظم القلب البطيء أو غير المنتظم أو بانخفاض وظائف القلب )فشل القلب(: لا يوصى<br />بالأزيثرومايسين.<br />&bull; أنت على دراية بأنك تعاني من انخفاض مستويات البوتاسيوم أو المغنسيوم في الدم: لا يوصى بالأزيثرومايسين.<br />&bull; تتناول أدوية تُعرف باسم مضادات اضطراب نظم القلب )على سبيل المثال: كينيدين، بروكاييناميد، دوفيتيليد، أميودارون، سوتالول:<br />تُستخدم لعلاج نظم القلب غير الطبيعي(، أو سيسابريد )يستخدم لعلاج اضطربات المعدة(، أو تيرفينادين )مضاد الهيستامين: يستخدم<br />لعلاج الحساسية(، أو العوامل المضادة للذهان )مثل بيموزيد(، ومضادات الاكتئاب )مثل سيتالوبرام(، وبعض المضادات الحيوية<br />)مثل موكسيفلوكساسين، ليفوفلوكساسين( التي يمكن أن تؤثر في نظم القلب: لا يوصى بالأزيثرومايسين )انظر &quot;أدوية أخرى<br />وزينسين&quot; أدناه(.<br />إذا أصبت بإسهال شديد ومستمر خلال العلاج أو بعد انتهائه، خاصة إذا لاحظت دمًا أو مخاطًا، فأخبر طبيبك على الفور.<br />في حال استمرت الأعراض بعد نهاية العلاج بدواء زينسين أو إذا لاحظت أي أعراض مستمرة جديدة، فتواصل مع الطبيب.<br />الأدوية الأخرى و زينسين<br />أخبر طبيبك قبل تناول زينسين، إذا كنت تتناول أيًا من هذه الأدوية المدرجة أدناه:<br />&bull; الوارفارين أو أي دواء مماثل لمنع تجلط الدم: يمكن أن يزيد الاستخدام المتزامن خطر النزيف.<br />&bull; أرجوتامين، ثنائي هيدروأرجوتامين )يُستخدم لعلاج الصداع النصفي(: قد تصاب بالأرجوتية )أي الحكة في الأطراف وتشنجات<br />العضلات وغرغرينا في اليدين والقدمين بسبب ضعف الدورة الدموية(. لذلك لا يوصى بالاستخدام المتزامن.<br />&bull; سيكلوسبورين )يُستخدم لتثبيط جهاز المناعة لمنع وعلاج رفض العضو أو زرع النخاع العظمي(: إذا كان الاستخدام المتزامن لازمًا،<br />فسيفحص طبيبك مستويات الدم بانتظام وقد يعدل الجرعة.<br />&bull; الديجوكسين )لعلاج قصور القلب(: قد يزيد مستويات الديجوكسين. سيفحص طبيبك مستويات الدم.<br />&bull; الكولشيسين )يُستخدم لعلاج النقرس وحمى البحر الأبيض المتوسط العائلية(.<br />&bull; مضادات الحموضة )لعلاج عسرالهضم(: يجب تناول أزيثرومايسين على الأقل قبل ساعة من تناول مضاد الحموضة، أو بعده<br />بساعتين.<br />&bull; سيسابريد )لعلاج اضطرابات المعدة(، أو تيرفينادين )يُستخدم لعلاج حمى القش(: قد يسبب الاستخدام المتزامن مع أزيثرومايسين<br />حدوث اضطرابات في القلب.<br />&bull; أدوية لعلاج ضربات القلب غير المنتظمة )يطلق عليها مضادات اضطراب نظم القلب( أو لخفض الكوليسترول )يطلق عليها<br />ستاتينات( مثل أتورفاستاتين.<br />&bull; ألفنتانيل )يستخدم للتخدير( أو أستيمزول )يستخدم لعلاج حمى القش(: الاستخدام المتزامن مع أزيثرومايسين قد يزيد من تأثير<br />هذه الأدوية.<br />أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى.</p><p>الحمل والرضاعة الطبيعية<br />إذا كنتِ حاملاً أو ترضعين طفلك أو تعتقدين أنك حامل أو تخططين للحمل، فعليكِ استشارة طبيبك أو الصيدلي قبل تناول هذا الدواء.<br />الحمل<br />لا تتوفر معلومات كافية عن سلامة أزيثرومايسين خلال الحمل. لذا، لا يوصى باستخدام أزيثرومايسين إذا كنتِ حاملاً أو تخططين<br />لإنجاب طفل. ومع ذلك، قد يصفه لكِ طبيبك في الحالات الخطيرة.<br />الرضاعة الطبيعية<br />يتسرب زينسين إلى حليب الأم، لذلك لا يجب القيام بالرضاعة الطبيعية في أثناء تناول زينسين، فقد يسبب آثارًا جانبية لطفلك تشمل<br />الإسهال والالتهابات. يوصى بالتخلص من الحليب في أثناء العلاج ولمدة تصل إلى يومين بعد وقف العلاج. ويمكن استئناف الرضاعة<br />الطبيعية بعد يومين من وقف العلاج بأزيثرومايسين.<br />القيادة واستخدام الآلات<br />قد يسبب أزيثرومايسين الدوخة والنوبات. في حالة تعرضك لذلك، لا تقُد أو تشغّل الآلات.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء دائمًا وفقًا للجرعة التي وصفها لك الطبيب أو الصيدلي بالضبط. يجب مراجعة طبيبك أو الصيدلي إذا لم تكن متأكدًا.<br />يجب تناول أقراص زينسين كجرعة واحدة يوميًا. يفضل ابتلاع الأقراص مع الماء، ومن الممكن تناولها مع الطعام أو من دونه.<br />زينسين 500 ملغ: لا يمكن تقسيم القرص على جرعات متساوية.<br />الجرعة الموصي بها هي:<br />البالغون )بمن في ذلك المرضى كبار السن( والأطفال والمراهقون الذين يزيد وزنهم عن 45 كجم:<br />الجرعة الموصي بها هي 1500 ملغ تُقسم إما على ثلاثة أيام أو خمسة أيام كالتالي:<br />&bull; في حالة تناوله على مدار 3 أيام، يؤخذ 500 ملغ مرة واحدة يوميًا.<br />&bull; في حالة تناوله على مدار 5 أيام، يؤخذ 500 ملغ كجرعة واحدة في اليوم الأول، ثم 250 ملغ مرة واحدة يوميًا من اليوم<br />الثاني إلى الخامس.<br />التهابات مجرى البول أو عنق الرحم الناتجة عن المتدثرة )كلايميديا(: 1000 ملغ كجرعة واحدة لمدة يوم واحد فقط.<br />التهابات الجيوب الأنفية: يوصف لعلاج البالغين والمراهقين الذين يبلغ عمرهم 16 عامًا أو أكثر.<br />الأطفال والمراهقون الذين يبلغ وزنهم 45 كجم وأقل:<br />لا توصف الأقراص لهذه الفئة من المرضى. قد تُستخدم الأشكال الصيدلانية الأخرى من المنتجات المحتوية على أزيثرومايسين<br />)على سبيل المثال، المحاليل المعلقة(.<br />المرضى الذين يعانون من مشكلات في الكلى أو الكبد:<br />يجب إخبار طبيبك إذا كنت تعاني من مشكلات في الكلى أو الكبد، فقد يحتاج طبيبك إلى تغيير الجرعة المعتادة.<br />استكمل دائمًا مدة العلاج حتى إذا شعرت بتحسن. وفي حالة تفاقم العدوى أو عدم الشعور بحالة أفضل خلال بضعة أيام أو في حالة<br />الإصابة بعدوى جديدة، فراجع طبيبك مرة أخرى.<br />إذا تناولت زينسين أكثر من اللازم<br />إذا ابتلعت أنت )أو شخص آخر( عددًا من الأقراص معًا، أو إذا كنت تعتقد أن طفلاً ابتلع أيًا من الأقراص، فاتصل بالطبيب أو الصيدلي<br />على الفور. من المرجح أن تسبب الجرعة الزائدة فقدانًا في السمع يمكن ارجاعه ، وغثيانًا شديدًا )الشعور بالإعياء( والقيء والإسهال.<br />يرجى أخذ هذه النشرة وأي أقراص متبقية والعبوة معك إلى المستشفى أو الطبيب، حتى يستطيع معرفة أي أقراص قد تم تناولها.<br />إذا نسيت تناول زينسين<br />إذا نسيت تناول القرص، فتناول القرص بمجرد أن تتذكره، ما لم يقترب من موعد تناول الجرعة التالية. لا تتناول جرعة مضاعفة<br />لتعوض الجرعات المنسية.<br />إذا توقفت عن تناول زينسين<br />لا تتوقف عن تناول هذا الدواء من دون التحدث مع طبيبك أولاً حتى إذا شعرت بتحسن. من المهم للغاية الاستمرار في تناول<br />أزيثرومايسين على مدار المدة التي وصفها لك الطبيب، وإلا فقد تتكرر الإصابة بالعدوى.<br />إذا كانت لديك أي أسئلة أخرى عن استخدام هذا الدواء، فاسأل طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل كافة الأدوية، قد يسبب هذا الدواء أعراضاً جانبية على الرغم من عدم حدوثها لكل الأشخاص.<br />في حالة حدوث الأعراض التالية، توقف عن تناول الأقراص وأخبر طبيبك على الفور، أو توجه إلى قسم الطوارئ في أقرب<br />مستشفى:<br />غير شائعة )قد تُصيب ما يصل إلى شخص واحد من بين كل 100 شخص(:<br />&bull; رد فعل جلدي شديد يسبب ظهور بثور/نزيف في الشفتين والعينين والأنف والفم والأعضاء التناسلية )متلازمة ستيفنز جونسون(.<br />&bull; اصفرار الجلد وبياض العيون وتعب وفقدان الشهية، وهو ما قد يكون ناتجاً عن التهاب في الكبد )التهاب الكبد(.<br />نادرة )قد تُصيب ما يصل إلى شخص واحد من بين كل 1000 شخص(:<br />&bull; اصفرار الجلد أو العينين )اليرقان(.<br />&bull; تهيج الجلد الذي يظهر في صورة الظهور السريع لمناطق حمراء في الجلد مع بثور صغيرة )حبوب صغيرة مملوءة بسائل<br />أبيض/أصفر(.<br />نادرة )قد تُصيب ما يصل إلى شخص واحد من بين كل 10000 شخص(:<br />&bull; الطفح الجلدي المصحوب بأعراض أخرى مثل الحمى وتورم الغدد وزيادة اليوزينيات )نوع من خلايا الدم البيضاء(.<br />غير معروفة )لا يمكن تقدير عدد مرات تكرارها بناءً عن البيانات المتاحة(:<br />&bull; رد فعل تحسسي )تورم الشفتين أو الوجه أو الرقبة الذي يؤدي إلى صعوبة شديدة في التنفس، الطفح الجلدي أو الشرى(.<br />&bull; تقشر شديد في الجلد أو طفح مثير للحكة مصحوبًا بدوائر وردية محمرة حول مركز التقشر )انحلال البشرة النخري السُمي،<br />حمامي عديدة الأشكال(.<br />تأخير توصيل الإشارات الكهربائية ويمكن رؤيته عبر تخطيط كهربية ( QT &bull; اضطرابات في نظم القلب يطلق عليها اسم إطالة<br />القلب وهو تسجيل كهربائي للقلب(. يمكن أن تتطور هذه الاضطرابات لدى بعض الأشخاص إلى حالة خطيرة محتملة في القلب،<br />تُعرف باسم تورساد دي بوانت. ويمكن أن يؤدي هذا إلى زيادة سرعة ضربات القلب بشدة، مما يتسبب في فقدان الوعي المفاجئ.<br />&bull; ضربات القلب غير المنتظمة.<br />&bull; الشعور بالتعب وانقطاع النفس مع اصفرار الجلد، وهو ما قد يكون ناتجًا عن انخفاض عدد خلايا الدم الحمراء بسبب التدمير<br />)فقر الدم الانحلالي(.<br />&bull; الإسهال طويل المدة المصحوب بدم ومخاط.</p><p dir="RTL">&bull; ألم في المعدة ينتقل إلى الظهر مع الشعور بالتعب والإعياء الذي قد يكون ناتجًا عن التهاب في البنكرياس )التهاب البنكرياس(.<br />&bull; ألم في منتصف الظهر ومشكلات في التبول أو التهاب الكلى أو فشل الكلى.<br />&bull; ألم في الجزء الأيمن العلوي من المعدة، مع الشعور بالتعب والإعياء وتورم المعدة.<br />&bull; اصفرار الجلد والعينين وهو ما قد يكون ناتجًا عن فشل الكبد )نادرًا ما يكون مهددًا للحياة(.<br />&bull; النوبات.<br />تعد هذه الأعراض الجانبية خطيرة جدًا. وقد تحتاج إلى العناية الطبية العاجلة أو الإقامة في المستشفى.<br />تم الإبلاغ عن الآثار الجانبية التالية:<br />شائعة جدًا )قد تُصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص(:<br />&bull; الإسهال.<br />&bull; الشعور بالإعياء.<br />&bull; ألم في البطن.<br />&bull; انتفاخ البطن )ريح(.<br />شائعة )قد تُصيب ما يصل إلى شخص واحد من بين كل 10 أشخاص(:<br />&bull; الصداع<br />&bull; الدوخة، الشعور بالنعاس، اضطرابات التذوق، الخدر أو وخز وتنميل )الخدران(.<br />&bull; اضطرابات الرؤية.<br />&bull; الصمم.<br />&bull; الإصابة بالإعياء.<br />&bull; عسر الهضم.<br />&bull; الطفح الجلدي.<br />&bull; الحكة.<br />&bull; ألم المفاصل )ألم مفصلي(.<br />&bull; التعب.<br />&bull; تغيرات في عدد خلايا الدم البيضاء في اختبارات الدم.<br />&bull; انخفاض البيكربونات في الدم.</p><p dir="RTL">غير شائعة )قد تُصيب ما يصل إلى شخص واحد من بين كل 100 شخص(:<br />&bull; انخفاض حاسة اللمس أو الإحساس )نقص الحس(.<br />&bull; تغيرات في وظائف الكبد.<br />&bull; زيادة حساسية الجلد للضوء عن المعتاد.<br />&bull; عدوى الخميرة في الفم والمهبل )السُلاق(، التهابات المهبل، الالتهابات الفطرية، العدوى البكتيرية، التهاب الحلق، التهاب المعدة<br />والأمعاء، صعوبات في التنفس، سيلان أو انسداد الأنف.<br />&bull; رد فعل تحسسي مختلف الشدة.<br />&bull; فقدان الشهية.<br />&bull; الشعور بالتوتر.<br />&bull; الأرق.<br />&bull; اضطرابات الأذن، الدوار.<br />&bull; ضعف السمع، بما في ذلك فقدان السمع.<br />&bull; الطنين )رنين في الأذن(.<br />&bull; خفقان القلب.<br />&bull; هبات ساخنة.<br />&bull; تكرار الإصابة بحالات العدوى المتكررة المصحوبة بحمى، قشعريرة، احتقان الحلق، وتقرحات الفم؛ والتي قد تنتج عن نقص<br />عدد خلايا الدم البيضاء في الدم.<br />&bull; عدوى رئوية خطيرة مع أعراض مثل الحمى، القشعريرة، ضيق التنفس، السعال المصحوب ببلغم )الالتهاب الرئوي(.<br />&bull; تورم عام.<br />&bull; نزيف الأنف.<br />&bull; الإمساك، التهاب بطانة المعدة )التهاب المعدة(، صعوبة البلع، الشعور بالانتفاخ، جفاف الفم، التجشؤ، قروح الفم، زيادة اللعاب.<br />&bull; الشرى، التهاب الجلد )التهابات الجلد(، جفاف الجلد، زيادة التعرق.<br />&bull; ألم في العظام والمفاصل، الم في العضلات، ألم في الظهر، ألم في الرقبة.<br />&bull; ألم عند التبول، ألم في الكلى.<br />&bull; نزيف غير معتاد أو غير متوقع من المهبل.<br />&bull; مشكلات في الخصيتين.<br />&bull; فقدان عام في القوة، شعور عام بالإعياء، تورم الوجه، ألم في الصدر، حمي، ألم، تورم في الأطراف السفلية.<br />&bull; قيم غير معتادة في الاختبارات المعملية )على سبيل المثال، اختبارات الدم والكبد(.<br />&bull; مضاعفات ما بعد العملية.<br />&bull; ضيق التنفس.<br />نادرة جدا )قد تُصيب ما يصل إلى شخص واحد من بين كل 1000 شخص(:<br />&bull; الإنفعال.<br />&bull; الدوخة.</p><p dir="RTL">غير معروفة )لا يمكن تقدير عدد مرات تكرارها بناءً عن البيانات المتاحة(:<br />&bull; يستغرق الدم وقتًا أطول للتخثر وتزيد سهولة الإصابة بالكدمات، وهو ما قد يرجع إلى انخفاض عدد الصفائح )قلة الصفيحات(.<br />&bull; عدوان، قلق، ارتباك شديد )هذيان(، رؤية أو إحساس أو سماع أشياء غير موجودة )الهلوسة(.<br />&bull; الإغماء، الشعور بفرط النشاط، فقدان الشم أو تغير حاسة الشم، فقدان الإحساس.<br />&bull; ضعف العضلات أو سوء حالة ضعف العضلات )الوهن العضلي الوبيل(.<br />&bull; انخفاض ضغط الدم.<br />&bull; تغير لون اللسان.<br />&bull; تغير لون الأسنان.<br />تم الإبلاغ عن الآثار الجانبية التالية خلال العلاج الوقائي لمركب المتفطرات الطيرية:<br />شائع جدًا )قد يؤثر على أكثر من 1 من بين كل 10 أشخاص(:<br />&bull; الإسهال.<br />&bull; ألم في البطن<br />&bull; الشعور بالإعياء.<br />&bull; ريح.<br />&bull; اضطراب في البطن.<br />&bull; البراز الرخو.<br />شائع )قد يؤثر على ما يصل إلى 1 من بين كل 10 أشخاص(:<br />&bull; فقدان الشهية.<br />&bull; الدوخة.<br />&bull; الصداع.<br />&bull; الخدر أو وخز وتنميل )الخدران(.<br />&bull; اضطراب التذوق.<br />&bull; اضطرابات الرؤية.<br />&bull; الصمم.<br />&bull; الطفح الجلدي و/أو الحكة.<br />&bull; ألم المفاصل.<br />&bull; التعب.<br />غير شائعة )قد تُصيب ما يصل إلى 1 من بين كل 100 شخص(:<br />&bull; انخفاض حاسة اللمس أو الإحساس )نقص الحس(.<br />&bull; ضعف السمع أو رنين في الأذنين.<br />&bull; خفقان القلب.<br />&bull; زيادة حساسية الجلد لضوء الشمس عن المعتاد.<br />&bull; فقدان عام في القوة.<br />&bull; شعور عام بالإعياء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&bull; احتفظ بهذا الدواء بعيدًا عن متناول ومرأى الأطفال.<br />&bull; يُحفظ في درجة حرارة أقل من 30 درجة مئوية.<br />&bull; لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على العبوة. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.<br />&bull; لا تتخلص من أي دواء عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم<br />تعد بحاجة لاستخدامها. سوف تساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحتوي كل قرص مغلف من زينسين على ما يلي:<br />&bull; المادة الفعالة هي أزيثرومايسين.<br />يحتوي كل قرص إما على 250 ملغ أو 500 ملغ من المادة الفعالة أزيثرومايسين )في شكل ثنائي هيدرات أزيثرومايسين(.<br />&bull; المكونات الأخرى هي: سليولوز دقيق التبلور، نشاء الذرة المعدل، سلفات لوريل الصوديوم، فوسفات ثنائي الكالسيوم اللامائي،<br />سترات المغنسيوم، أوبادري أبيض.&nbsp; كروس كارميلوز الصوديوم، بروفيدون 30k<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ما شكل زينسين ؟ وما محتويات العبوة؟<br />على جانب واحد ودون أي كتابة مطبوعة &rsquo;C| زينسين أقراص مغلفة 250 ملغ: لونها أبيض، محدبة الوجهين ومغلفة، محفور &lsquo; 25<br />على الجانب الآخر.<br />على جانب واحد و&lsquo;/&rsquo; على الجانب الآخر. &rsquo;C زينسين أقراص مغلفة 500 ملغ: لونها أبيض، محدبة الوجهين ومغلفة، محفور &lsquo; 64<br />تتوفر أقراص 250 ملغ في عبوة تحتوي على 6 أقراص في شريطين.<br />تتوفر أقراص 500 ملغ في عبوة تحتوي على 3 أقراص في شريط واحد.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة الشرق الأوسط للصناعات الدوائية المحدودة</p><p>(أفالون فارما)</p><p>ص.ب. 4180 الرياض 11491</p><p>المدينة الصناعية الثانية، الرياض، المملكة العربية السعودية</p><p>هاتف</p><p>0966112653948 &ndash; 00966112653427</p><p>فاكس</p><p>00966112654723</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05/2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zencin®250mg Film-coated Tablets 
Zencin®500mg Film-coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Zencin®250mg: Each 250 mg film-coated tablet contains 250 mg azithromycin (as azithromycin dihydrate).
Zencin®500 mg: Each 500 mg film-coated tablet contains 500 mg azithromycin (as azithromycin dihydrate). For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet.
Azithromycin 250 mg Film-coated Tablets are white tablet shaped, biconvex, film coated tablet debossed with ‘C|25’ on one side and plain on the other side.
Azithromycin 500 mg Film-coated Tablets are white tablet shaped, biconvex, film coated tablet debossed with ‘C64’ on one side and ‘/’ on the other side.
The tablet can’t be divided into equal doses.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Azithromycin is indicated for the treatment of the following infections, when caused by microorganisms sensitive to azithromycin (see section 4.4 and 5.1):<br />&bull; Acute bacterial sinusitis (adequately diagnosed)<br />&bull; Acute bacterial otitis media (adequately diagnosed)<br />&bull; Pharyngitis, tonsillitis<br />&bull; Acute exacerbation of chronic bronchitis (adequately diagnosed)<br />&bull; Mild to moderately severe community acquired pneumonia<br />&bull; Infections of the skin and soft tissues of mild to moderate severity e.g. folliculitis, cellulitis, erysipelas<br />&bull; Uncomplicated Chlamydia trachomatis urethritis and cervicitis<br />Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Azithromycin tablets should be given as a single daily dose. The duration of treatment in each of the infectious diseases is given below.<br />Adults, elderly, children and adolescents over 45 kg body weight<br />The total dosage of azithromycin is 1500 mg which is spread over three days (500 mg once daily).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to erythromycin or any macrolide or ketolide antibiotic.or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Allergic reactions<br />As with erythromycin and other macrolides, rare serious allergic reactions including angioneurotic oedema and anaphylaxis (rarely fatal) have been reported alongside dermatological reactions, including acute generalised exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) (rarely fatal) and DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms). A certain number of these reactions resulted in recurring symptoms and required an extended period of observation and treatment.<br />If an allergic reaction occurs, use of this medicinal product must be discontinued and the appropriate treatment initiated. Doctors must be aware that allergic symptoms can recur if symptomatic treatment is discontinued.<br />Renal impairment<br />No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance &gt; 40 ml/min). In patients with severe renal function impairment (GFR &lt; 10 mL/min), a 33% increase in systemic exposure to azithromycin has been observed (see section 5.2).</p><p>Hepatic impairment<br />Since liver is the principal route of elimination for azithromycin, the use of azithromycin should be undertaken with caution in patients with significant hepatic disease. Cases of fulminant hepatitis potentially leading to life- threatening liver failure have been reported with azithromycin (see section 4.8). Some patients may have, or have had pre-existing hepatic disease or may have been taking other hepatotoxic medicinal products.<br />In case of signs and symptoms of liver dysfunction, such as rapid developing asthenia associated with<br />jaundice, dark urine, bleeding tendency or hepatic encephalopathy, liver function tests/ investigations should be performed immediately. Azithromycin administration should be stopped if liver dysfunction has emerged.<br />Liver function disorders, hepatitis, cholestatic jaundice, liver necrosis and renal failure have been reported and have been fatal in a number of cases. Discontinue the use of azithromycin if signs and symptoms of hepatitis occur.<br />Pseudomembranous colitis has been reported following use of macrolide antibiotics. This diagnosis should therefore be taken into consideration in patients who develop diarrhoea after starting treatment with azithromycin.<br />Infantile hypertrophic pyloric stenosis<br />Following the use of azithromycin in neonates (treatment up to 42 days of life), infantile hypertrophic pyloric stenosis (IHPS) has been reported. Parents and caregivers should be informed to contact their physician if vomiting or irritability with feeding occurs.<br />Ergot alkaloids and azithromycin<br />The concurrent use of ergot alkaloids and macrolide antibiotics has been found to accelerate the development of ergotism. The interactions between ergot alkaloids and azithromycin have not been studied. The development of ergotism is however possible, so that azithromycin and ergot alkaloid derivatives should not be administered simultaneously.<br />QT prolongation<br />Prolonged cardiac repolarisation and a prolonged QT interval, imparting a risk of developing cardiac arrhythmia and torsades de pointes, have been seen in treatment with other macrolides including azithromycin (see section 4.8).<br />Therefore, as the following situations may lead to an increased risk for ventricular arrhythmias (including torsade de pointes) which can lead to cardiac arrest, azithromycin should be used with caution in patients with ongoing proarrhythmic conditions (especially women and elderly patients) such as:<br />&bull; Patients with congenital or documented acquired QT prolongation.<br />&bull; Patients currently receiving treatment with other active substances that prolong QT interval such as antiarrhythmics of class IA (quinidine and procainamide) and class III (dofetilide, amiodarone and sotalol), cisapride and terfenadine; antipsychotic agents such as pimozide; antidepressants such as citalopram; and fluoroquinolones such as moxifloxacin and levofloxacin (see section 4.5).<br />&bull; Patients with a disrupted electrolyte balance, particularly in cases of hypokalaemia and hypomagnesaemia<br />&bull; Patients with clinically relevant bradycardia, cardiac arrhythmia or severe cardiac insufficiency.<br />Myasthenia gravis and azithromycin<br />Exacerbations of the symptoms of myasthenia gravis and new onset of myasthenia syndrome have been reported in patients receiving azithromycin therapy (see section 4.8).</p><p>Superinfections<br />As with any antibiotic preparation, observation for signs of superinfection with non-susceptible organisms, including fungi is recommended.<br />Clostridium difficile associated diarrhoea<br />Clostridium difficile associated diarrhoea (CDAD) has been reported with use of nearly all antibacterial agents, including azithromycin, and may range in severity from mild diarrhoea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.<br />C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhoea following antibiotic use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.<br />The following should be considered before prescribing azithromycin:<br />Azithromycin film-coated tablets are not suitable for treatment of severe infections where a high concentration of the antibiotic in the blood is rapidly needed.<br />As for other macrolides, high resistance rates of Streptococcus pneumoniae have been reported for azithromycin in some European countries (see section 5.1). This should be taken into account when treating infections caused by Streptococcus pneumoniae.<br />The main causative agent of soft tissue infections, Staphylococcus aureus, is frequently resistant to azithromycin. Therefore, susceptibility testing is considered a precondition for treatment of soft tissue infections with azithromycin.<br />Pharyngitis/tonsillitis<br />Azithromycin is not the substance of first choice for the treatment of pharyngitis and tonsillitis caused<br />by Streptococcus pyogenes. For this and for the prophylaxis of acute rheumatic fever penicillin is the treatment of first choice.<br />Sinusitis<br />Often, azithromycin is not the substance of first choice for the treatment of sinusitis.<br />Acute otitis media<br />Often, azithromycin is not the substance of first choice for the treatment of acute otitis media.<br />Infected burn wounds<br />Azithromycin is not indicated for the treatment of infected burn wounds.<br />Sexually transmitted disease<br />In case of sexually transmitted diseases a concomitant infection by T. pallidum should be excluded.<br />Neurological or psychiatric diseases<br />Azithromycin should be administered with caution to patients suffering from neurological or psychiatric diseases.<br />Long-term use There is no experience regarding the safety and efficacy of long-term use of azithromycin for the mentioned indications. In case of rapid recurrent infections, treatment with another antibiotic should be considered.</p><p>Due to cross-resistance existing among macrolides, in areas with a high incidence of erythromycin resistance, it is especially important to take into consideration the evolution of the pattern of susceptibility to azithromycin and other macrolides (see section 5.1).<br />Azithromycin is not the first choice for the empirical treatment of infections in areas where the prevalence of resistant isolates is 10% or more (see section 5.1).<br />Paediatric population<br />Safety and efficacy for the prevention or treatment of Mycobacterium Avium Complex in children have not been established.</p><p>The following should be considered before prescribing azithromycin:<br />Azithromycin film-coated tablets are not suitable for treatment of severe infections where a high concentration of the antibiotic in the blood is rapidly needed.<br />As for other macrolides, high resistance rates of Streptococcus pneumoniae have been reported for azithromycin in some European countries (see section 5.1). This should be taken into account when treating infections caused by Streptococcus pneumoniae.<br />The main causative agent of soft tissue infections, Staphylococcus aureus, is frequently resistant to azithromycin. Therefore, susceptibility testing is considered a precondition for treatment of soft tissue infections with azithromycin.<br />Pharyngitis/tonsillitis<br />Azithromycin is not the substance of first choice for the treatment of pharyngitis and tonsillitis caused<br />by Streptococcus pyogenes. For this and for the prophylaxis of acute rheumatic fever penicillin is the treatment of first choice.<br />Sinusitis<br />Often, azithromycin is not the substance of first choice for the treatment of sinusitis.<br />Acute otitis media<br />Often, azithromycin is not the substance of first choice for the treatment of acute otitis media.<br />Infected burn wounds<br />Azithromycin is not indicated for the treatment of infected burn wounds.<br />Sexually transmitted disease<br />In case of sexually transmitted diseases a concomitant infection by T. pallidum should be excluded.<br />Neurological or psychiatric diseases<br />Azithromycin should be administered with caution to patients suffering from neurological or psychiatric diseases.<br />Long-term use<br />There is no experience regarding the safety and efficacy of long-term use of azithromycin for the mentioned indications. In case of rapid recurrent infections, treatment with another antibiotic should be considered.</p><p>Due to cross-resistance existing among macrolides, in areas with a high incidence of erythromycin resistance, it is especially important to take into consideration the evolution of the pattern of susceptibility to azithromycin and other macrolides (see section 5.1).<br />Azithromycin is not the first choice for the empirical treatment of infections in areas where the prevalence of resistant isolates is 10% or more (see section 5.1).<br />Paediatric population<br />Safety and efficacy for the prevention or treatment of Mycobacterium Avium Complex in children have not been established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Antacids<br />When studying the effect of simultaneously administered antacid on the pharmacokinetics of azithromycin, no overall change has been observed in the bioavailability, although the peak concentrations of azithromycin measured in the plasma reduced by approximately 25 %. In patients receiving both azithromycin and antacids, the drugs should not be taken simultaneously. Azithromycin should be taken at least 1 hour before or 2 hours after the antacid.<br />Cetirizine<br />In healthy volunteers, coadministration of a 5-day regimen of azithromycin with cetirizine 20 mg at steady-state resulted in no pharmacokinetic interaction and no significant changes in the QT interval.<br />Didanosine (Dideoxyinosine)<br />Coadministration of 1200 mg/day azithromycin with 400 mg/day didanosine in 6 HIV-positive subjects did not appear to affect the steady-state pharmacokinetics of didanosine as compared with placebo.<br />Digoxin and colchicine (P-gp substrates)<br />Concomitant administration of macrolide antibiotics, including azithromycin, with P-glycoprotein substrates such as digoxin and colchicine, has been reported to result in increased serum levels of the P-glycoprotein<br />substrate. Therefore, if azithromycin and P-gp substrates such as digoxin are administered concomitantly, the possibility of elevated serum concentrations of the substrate should be considered. During treatment with azithromycin and after discontinuation, clinical monitoring, and possible follow-up of serum digoxin levels, is required.<br />Zidovudine<br />Single 1000 mg doses and multiple 1200 mg or 600 mg doses of azithromycin had little effect on the plasma pharmacokinetics or urinary excretion of zidovudine or its glucuronide metabolite. However, administration of azithromycin increased the concentrations of phosphorylated zidovudine, the clinically active metabolite, in peripheral blood mononuclear cells. The clinical significance of this finding is unclear, but it may be of benefit to patients.<br />Azithromycin does not interact significantly with the hepatic cytochrome P450 system. It is not believed to undergo the pharmacokinetic drug interactions as seen with erythromycin and other macrolides. Hepatic cytochrome P450 induction or inactivation via cytochrome-metabolite complex does not occur with azithromycin.<br />Ergot derivatives<br />Due to the theoretical possibility of ergotism, the concurrent use of azithromycin with ergot derivatives is not recommended (see section 4.4).</p><p>Pharmacokinetic studies have been conducted between azithromycin and the following medicinal products known to undergo significant cytochrome P450 mediated metabolism.<br />Astemizole and alfentanil<br />No data are available on interactions with astemizole and alfentanil. Caution should be exercised with concomitant use of these agents and azithromycin in view of the described potentiation of its effect during concomitant use of the macrolide antibiotic erythromycin.<br />Atorvastatin<br />Coadministration of atorvastatin (10 mg daily) and azithromycin (500 mg daily) did not alter the plasma concentrations of atorvastatin (based on a HMG CoA-reductase inhibition assay). However, post-marketing cases of rhabdomyolysis in patients receiving azithromycin with statins have been reported.<br />Carbamazepine<br />In a pharmacokinetic interaction study in healthy volunteers, no significant effect was observed on the plasma levels of carbamazepine or its active metabolite in patients receiving concomitant azithromycin.<br />Cisapride<br />Cisapride is metabolised in the liver by the enzyme CYP 3A4. Because macrolides inhibit this enzyme, concomitant administration of cisapride may cause the increase of QT interval prolongation, ventricular arrhythmias and torsades de pointes.<br />Cimetidine<br />In a pharmacokinetic study investigating the effects of a single dose of cimetidine, given 2 hours before azithromycin, on the pharmacokinetics of azithromycin, no alteration of azithromycin pharmacokinetics was seen.<br />Coumarin-Type Oral Anticoagulants<br />In a pharmacokinetic interaction study, azithromycin did not alter the anticoagulant effect of a single 15 mg dose of warfarin administered to healthy volunteers. There have been reports received in the post-marketing period of potentiated anticoagulation subsequent to coadministration of azithromycin and coumarin type oral anticoagulants. Although a causal relationship has not been established, consideration should be given to the frequency of monitoring prothrombin time when azithromycin is used in patients receiving coumarin-type oral anticoagulants.<br />Ciclosporin<br />In a pharmacokinetic study with healthy volunteers that were administered a 500 mg/day oral dose of azithromycin for 3 days and were then administered a single 10 mg/kg oral dose of ciclosporin, the resulting ciclosporin Cmax and AUC0-5 were found to be significantly elevated. Consequently, caution should be exercised before considering concurrent administration of these medicinal products. If coadministration of these medicinal products is necessary, ciclosporin levels should be monitored and the dose adjusted accordingly.<br />Efavirenz<br />Coadministration of a 600 mg single dose of azithromycin and 400 mg efavirenz daily for 7 days did not result in any clinically significant pharmacokinetic interactions.</p><p>Coadministration of a single dose of 1200 mg azithromycin did not alter the pharmacokinetics of a single dose of 800 mg fluconazole. Total exposure and half-life of azithromycin were unchanged by the coadministration of fluconazole, however, a clinically insignificant decrease in Cmax (18%) of azithromycin was observed.<br />Indinavir<br />Coadministration of a single dose of 1200 mg azithromycin had no statistically significant effect on the pharmacokinetics of indinavir administered as 800 mg three times daily for 5 days.<br />Methylprednisolone<br />In a pharmacokinetic interaction study in healthy volunteers, azithromycin had no significant effect on the pharmacokinetics of methylprednisolone.<br />Midazolam<br />In healthy volunteers, coadministration of azithromycin 500 mg/day for 3 days did not cause clinically significant changes in the pharmacokinetics and pharmacodynamics of a single 15 mg dose of midazolam.<br />Nelfinavir<br />Coadministration of azithromycin (1200 mg) and nelfinavir at steady state (750 mg three times daily) resulted in increased azithromycin concentrations. No clinically significant adverse effects were observed and no dose adjustment is required.<br />Rifabutin<br />Coadministration of azithromycin and rifabutin did not affect the serum concentrations of either active. Neutropenia was observed in subjects receiving concomitant treatment of azithromycin and rifabutin. Although<br />neutropenia has been associated with the use of rifabutin, a causal relationship to combination with azithromycin has not been established (see section 4.8).<br />Sildenafil<br />In normal healthy male volunteers, there was no evidence of an effect of azithromycin (500 mg daily for 3 days) on the AUC and Cmax, of sildenafil or its major circulating metabolite.<br />Terfenadine<br />Pharmacokinetic studies have reported no evidence of an interaction between azithromycin and terfenadine. There have been rare cases reported where the possibility of such an interaction could not be entirely excluded; however there was no specific evidence that such an interaction had occurred.<br />Theophylline<br />There is no evidence of a clinically significant&nbsp;pharmacokinetic interaction when azithromycin and theophylline are co-administered to healthy volunteers.<br />Triazolam<br />In 14 healthy volunteers, coadministration of azithromycin 500 mg on Day 1 and 250 mg on Day 2 with 0.125 mg triazolam on Day 2 had no significant effect on any of the pharmacokinetic variables for triazolam compared to triazolam and placebo.<br />Trimethoprim/sulfamethoxazole<br />Coadministration of trimethoprim/sulfamethoxazole DS (160 mg/800 mg) for 7 days with azithromycin 1200 mg on Day 7 had no significant effect on peak concentrations, total exposure or urinary excretion of either trimethoprim or sulfamethoxazole. Azithromycin serum concentrations were similar to those seen in other studies.<br />Protease inhibitors<br />There are no data available about a possible interaction with protease inhibitors.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are no adequate data from use of azithromycin in pregnant women. In reproduction toxicity studies in animals, azithromycin was shown to pass the placenta, but no teratogenic effects were observed. The safety of azithromycin has not been confirmed with regard to the use of the active substance during pregnancy. Therefore, azithromycin should only be used during pregnancy if the benefit outweighs the risk.<br />Breast-feeding<br />Azithromycin passes into human breast milk, but there are no adequate and well-controlled clinical studies in nursing women that have characterised the pharmacokinetics of azithromycin excretion into human breast milk. Because it is not known whether azithromycin may have adverse effects on the breast-fed infant, nursing should be discontinued during treatment with azithromycin. Among other things diarrhoea, fungus infection of the mucous membrane as well as sensitisation is possible in the nursed infant. It is recommended to discard the milk during treatment and up until 2 days after discontinuation of treatment. Nursing may be resumed thereafter.<br />Fertility<br />In fertility studies conducted in rat, reduced pregnancy rates were noted following administration of azithromycin. The relevance of this finding to humans is unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed. However, the possibility of undesirable effects like dizziness and convulsions should be taken into account when performing these activities.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The table below lists the adverse reactions identified through clinical trial experience and post-marketing surveillance by system organ class and frequency The frequency grouping is defined using the following convention: Very common (&ge;1/10); Common (&ge; 1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare (&ge; 1/10,000 to &lt;1/1,000); Very Rare (&lt; 1/10,000); and Not known (cannot be estimated from the available&nbsp;data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.<br />Adverse reactions possibly or probably related to azithromycin based on clinical trial experience and post-marketing surveillance:</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse events experienced in higher than recommended doses were similar to those seen at normal doses. Characteristic symptoms of overdose with macrolide antibiotics include the following: reversible hearing loss, severe nausea, vomiting and diarrhoea.<br />In the event of overdosage, general symptomatic and supportive measures are indicated as required.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antibacterials for systemic use; macrolides. Azithromycin is a macrolide antibiotic belonging to the azalide group.<br />The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The chemical name of azithromycin is 9-deoxy-9a-aza-9a-methyl-9a-homo-erythromycin A. The molecular weight is 7Mechanism of action<br />www.avalonpharmaceutical.com<br />1.3 Product Information<br />1.3.1 Summary of product characteristics (SPC)<br />Zencin&reg;250mg and 500mg Film-coated Tablets<br />Azithromycin avoids the translocation of peptide chains from one side of the ribosome to the other by binding to the 50S ribosomal subunit. As a result, RNA-dependent protein synthesis in susceptible organisms is inhibited.<br />Cardiac electrophysiology :<br />QTc interval prolongation was studied in a randomised, placebo-controlled parallel trial in 116 healthy subjects, who received chloroquine (1000 mg), either alone or in combination with azithromycin (500 mg, 1000 mg and 1500 mg once daily). Concomitant administration of azithromycin increased the QTc interval in a dose and concentration-dependent manner. Compared to chloroquine alone, the maximum mean (95% upper confidence bound) increases in QTcF were 5 (10) ms, 7 (12) ms and 9 (14) ms with concomitant administration of 500 mg, 1000 mg and 1500 mg azithromycin, respectively.</p><p>Mechanism of resistance<br />The two most frequently encountered mechanisms of resistance to macrolides, including azithromycin, are target modification (most commonly by methylation of 23S rRNA) and active efflux. The occurrence of these resistance mechanisms varies from species to species, and within a single species, the frequency of resistance varies by geographical location.<br />The most important ribosomal modification that determines reduced binding of macrolides is post- transcriptional (N6)-dimethylation of adenine at nucleotide A2058 (Escherichia coli numbering system) of the 23S rRNA by methylases encoded by erm (erythromycin ribosome methylase) genes. Ribosomal modifications often determine cross resistance (MLSB phenotype) to other classes of antibiotics whose ribosomal binding sites overlap those of the macrolides: the lincosamides (including clindamycin), and the streptogramin B (which include, for example, the quinupristin component of quinupristin/dalfopristin). Different erm genes are present in different bacterial species, in particular Streptococci and Staphylococci. Susceptibility to macrolides can also be affected by less frequently encountered mutational changes in nucleotides A2058 and A2059, and at some other positions of 23S rRNA, or in the large subunit ribosomal proteins L4 and L22.<br />Efflux pumps occur in a number of species, including Gram-negatives, such as Haemophilus influenzae (where they may determine intrinsically higher MICs) and Staphylococci. In Streptococci and Enterococci, an efflux pump that recognises 14- and 15-membered macrolides (which include, respectively, erythromycin and azithromycin) is encoded by mef (A) genes.<br />A complete cross-resistance exists among erythromycin, azithromycin, other macrolides and lincosamides for Streptococcus pneumoniae, beta-haemolytic streptococci of group A, Enterococcus spp.<br />and Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA).<br />A decrease in macrolide susceptibility over time has been noted particularly<br />in Streptococcus pneumoniae and Staphylococcus aureus and is also observed in Streptococcus viridans and in Streptococcus agalactiae.<br />Penicillin-sensitive S. pneumoniae are more likely to be susceptible to azithromycin than are penicillin-resistant strains of S. pneumoniae. Methicillin-resistant S. aureus (MRSA) is less likely to be susceptible to azithromycin than methicillin-sensitive S. aureus (MSSA).<br />Susceptibility test breakpoints:<br />The EUCAST susceptibility criteria are listed in the table below. EUCAST Susceptibility Breakpoints for Azithromycin.</p><p>Susceptibility<br />The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.<br />Pathogens for which resistance may be a problem: prevalence of resistance is equal to or greater than 10% in at least one country in the European Union.</p><p>Following the assessment of studies conducted in children, the use of azithromycin is not recommended for the treatment of malaria, neither as monotherapy nor combined with chloroquine or artemisinin based drugs, as non-inferiority to anti-malarial drugs recommended in the treatment of uncomplicated malaria was not established.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Following oral administration the bio-availability of azithromycin is approximately 37%. Peak plasma levels are reached after 2-3 hours. The mean maximum concentration observed (Cmax) after a single dose of 500 mg is approximately 0.4 &mu;g/ml.<br />Distribution<br />Orally administered azithromycin is widely distributed throughout the body. Pharmacokinetic studies have shown considerably higher azithromycin concentrations in the tissues (up to 50 times the maximum concentration observed in the plasma). This indicates that the substance is extensively bound in the tissues (steady-state volume of distribution approximately 31 l/kg). The mean maximum observed serum concentration (Cmax) after a single dose of 500 mg is approx. 0.4 mg/mL, 2-3 hours after administration. With the recommended dosage no accumulation in the serum/plasma occurs. Accumulation does occur in the tissues where the levels are much higher than in the serum/plasma. Three days after administration of 500 mg as a single dose or in split doses, concentrations of 1.3 to 4.8 mg/g, 0.6 to 2.3 mg/g, 2.0 to 2.8 mg/g and 0 to 0.3 mg/mL were detected in lung, prostate, tonsil and serum respectively. Concentrations in these target tissues exceed the MIC90 for likely pathogens.<br />In experimental in vitro and in vivo studies, azithromycin accumulates in phagocytes; release is promoted by active phagocytosis. In animal models this process appears to contribute to the accumulation of azithromycin in tissue.<br />The binding of azithromycin to plasma proteins is variable and varies from 52% at 0.005 &mu;g/ml to 18% at 0.5 &mu;g/ml, depending on the serum concentration.<br />Biotransformation and Excretion<br />The terminal plasma elimination half-life follows the tissue depletion half-life of 2 to 4 days.<br />Approximately 12% of an intravenously administered dose is excreted in unchanged form with the urine over a period of 3 days; the major proportion in the first 24 hours. Concentrations of up to 237 &mu;g/ml azithromycin, 2 days after a 5-day course of treatment, have been found in human bile, together with 10 metabolites (formed by N- and O-demethylation, by hydroxylation of the desosamine and aglycone rings, and by splitting of the cladinose conjugate). Investigations suggests that the metabolites do not play a role in the micro-biological activity of azithromycin.<br />Pharmacokinetics in special populations Renal impairment</p><p>Following a single oral dose of azithromycin 1g, mean Cmax and AUC0-120 increased by 5.1% and 4.2% respectively, in subjects with mild to moderate renal impairment (glomerular filtration rate of 30-80 ml/min/1.73m2) compared with normal renal function (GFR &gt; 80 ml/min). In subjects with severe renal impairment (GFR &lt; 30 ml/min/1.73m2), the mean Cmaxand AUC0-120 increased 61% and 35% respectively compared to normal.<br />Hepatic impairment<br />In patients with mild to moderate hepatic impairment, there is no evidence of a marked change in serum pharmacokinetics of azithromycin compared to normal hepatic function. There are no data on azithromycin use in cases of more severe hepatic impairment.<br />Elderly<br />The pharmacokinetics of azithromycin in elderly men was similar to that of young adults; however, in elderly women, although higher peak concentrations (increased by 30-50%) were observed, no significant accumulation occurred.<br />In elderly volunteers (&gt;65 years), higher (29 %) AUC values were always observed after a 5-day course than in younger volunteers (&lt;45 years). However, these differences are not considered to be clinically relevant; no dose adjustment is therefore recommended.<br />Paediatric population<br />Pharmacokinetics have been studied in children aged 4 months &ndash; 15 years taking capsules, granules or suspension. At 10 mg/kg on day 1 followed by 5 mg/kg on days 2-5, the Cmax achieved is slightly lower than adults with 224 &mu;g/l in children aged 0.6-5 years and after 3 days dosing and 383 &mu;g/l in those aged 6-15 years. The t1/2 of 36h in the older children was within the expected range for adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In animal studies using exposures 40 times those achieved at the clinical therapeutic dosages, azithromycin was found to have caused reversible phospholipidosis, but as a rule there were no associated toxicological consequences. The relevance of this finding to humans receiving azithromycin in accordance with the recommendations is unknown.<br />Electrophysiological investigations have shown that azithromycin prolongs the QT interval.<br />Carcinogenic potential<br />Long-term studies in animals have not been performed to evaluate carcinogenic potential.<br />Mutagenic potential<br />There was no evidence of a potential for genetic and chromosome mutations in in vivo and in vitro test models.<br />Reproductive toxicity<br />No teratogenic effects were observed in embryotoxicity studies in rats after oral administration of azithromycin. In rats, azithromycin dosages of 100 and 200 mg/kg body weight/day led to mild retardations in fetal ossification and in maternal weight gain. In peri- and postnatal studies in rats, mild retardations following treatment with 50 mg/kg/day azithromycin and above were observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline Cellulose Pregelatinised Maize Starch Sodium Lauryl Sulphate<br />Dibasic Calcium Phosphate Anhydrous<br />Croscarmel- lose Sodium Povidone K30 Magnesium Stearate Opadry White.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product does not require any special storage conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The 250 mg tablets are available in pack size of 6 tablets in two blister strips.</p><p>The 500 mg tablets are available in pack size of 3 tablets in one blister strip.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Middle East Pharmaceutical Industries Co. Ltd (Avalon-Pharma)
2nd industrial City, P.O.Box 4180 Riyadh 11491, Kingdom of Saudi Arabia 
Tel: 920010564, Fax: +966 (11) 2654723
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Not applicable.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>